Research and Markets: Injectable Drugs Market in the US 2011-2015 – The Injectable Drugs Market in the US to Grow At A …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/sxkx5m/injectable_drugs_m) has announced the addition of the "Injectable Drugs Market in the US 2011-2015" report to their offering.

One of the key factors contributing to this market growth is the increasing prevalence of musculoskeletal diseases. The Injectable Drugs market in the US has also been witnessing the technological advancements in injecting devices. However, availability of counterfeit injectable drugs could pose a challenge to the growth of this market.

Key vendors dominating this market space include Amgen Inc., Johnson and Johnson Services Inc., Roche Holding Ltd., and Sanofi S.A. Other vendors mentioned in the report: Abbott Laboratories Inc., AstraZeneca plc, Baxter International Inc., Biogen Idec, Inc., Boehringer Ingelheim GmbH, Cumberland Pharmaceuticals Inc., Eli Lilly and Co., Fresenius SE and Co. KGaA, Hikma Pharmaceuticals plc, Hospira Inc., Medtronic Inc., Merck and Co. Inc., Novartis AG, Orchid Chemicals and Pharmaceuticals Ltd., and Pfizer Inc.

Commenting on the report, an analyst from TechNavio's Healthcare said; Injectable drugs are administered into the body through the intravenous delivery method. Vendors are continuously upgrading their injecting devices to ensure safety and to reduce pain. Moreover, vendors are developing pre-filled syringes that provide greater accuracy in delivering the injectable drugs into the body. Such devices eliminate the common risk of administering high doses to the patients, which can cause adverse side effects.

According to the report, there has been an increase in the prevalence of people suffering from different musculoskeletal diseases such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis in the US. This has created high demand for injectable drugs in the US because they are more effective in the treatment of these diseases than the other forms of drugs available in the market. This is one of the major drivers contributing to the growth of the market.

Further, the report also discusses that the problems associated with the storage of injectable drugs is a major challenge to the growth of the market.

For more information visit http://www.researchandmarkets.com/research/sxkx5m/injectable_drugs_m

See more here:
Research and Markets: Injectable Drugs Market in the US 2011-2015 - The Injectable Drugs Market in the US to Grow At A ...